Ex­clu­sive: Ul­ti­mate biotech in­sid­er Dan Lynch takes his 30 years of ex­pe­ri­ence to GV to fill a new­ly-cre­at­ed post

At every point over the past few years, Dan Lynch has filled a whole slate of board chair posts in the biotech world. He’s been the qui­et board leader at Blue­print Med­i­cines for the past 9 years — as the com­pa­ny went from be­ing a pure-play R&D out­fit to a drug mar­keter — and over the past decade helped coach 16 dif­fer­ent com­pa­nies as chair­man or board mem­ber, in­clud­ing blue­bird bio and Nim­bus.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER